Initial general form for registration of a class of securities pursuant to Section 12(g)

Description of Business (Details Narrative)

v3.22.2.2
Description of Business (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Jun. 25, 2021
Jun. 09, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2021
Fair market value of common stock      
Voting percent   51.00%      
Risk free rate   0.84%      
Volatility rate   250.00%      
Exit period   5 years      
Discount rate   35.00%      
Stock issued during period, shares, conversion of convertible securities   14,465,259      
Number of shares returned for cancellation   14,465,259      
Mr. Gerard Dab [Member]          
Number of shares exchanged   $ 200,000      
Fair market value of shares   $ 122,000      
Series B Convertible Redeemable Preferred Stock [Member]          
Percentage of shares for conversion 4.99%        
Series A Supermajority Voting Preferred Stock [Member]          
Number of shares issued on acquisition   1,000      
Series A Supermajority Voting Preferred Stock [Member] | Mr. Gerard Dab [Member]          
Number of shares issued on acquisition   1,000      
Number of shares exchanged   $ 300,000      
Voting percent   51.00%      
Series A Supermajority Voting Preferred Stock [Member] | Mr. Gerard Dab [Member]          
Number of shares exchanged   $ 300,000      
Series C Convertible Redeemable Preferred Stock [Member]          
Number of shares issued on acquisition   200      
Series C Convertible Redeemable Preferred Stock [Member] | Mr. Gerard Dab [Member]          
Number of shares issued on acquisition   200      
Number of shares exchanged   $ 200,000      
Fair market value of shares   $ 122,000      
Rennova Health, Inc. [Member] | Series B Convertible Redeemable Preferred Stock [Member]          
Number of shares issued 14,000   950    
Stated value per share $ 1,000        
Number of shares issued 14,950        
Fair market value of common stock $ 9,086,396